New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects
- PMID: 33878314
- DOI: 10.1016/j.yexmp.2021.104640
New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects
Abstract
Breast cancer (BC) has become one of the most common malignant tumors in the world, seriously endangering women's health and life. However, the underlying molecular mechanisms of BC remain unclear. Over the past decade, long non-coding RNAs (lncRNAs) were gradually discovered and appreciated to play pivotal regulatory role in the progression of BC. It has been demonstrated that lncRNAs are implicated in regulating plenty of biological phenomena including cell proliferation, apoptosis, invasion and metastasis by interacting with DNA, RNA or proteins. In addition to these, the function of lncRNAs in tumor resistance has increasingly attracted more attention. In this review, we summarized the emerging impact of lncRNAs on the occurrence and progression of human BC, specifically focusing on the functions and mechanisms of them, with the aim of exploring the potential value of lncRNAs as oncogenic drivers or tumor suppressors. Furthermore, the potential clinical application of lncRNAs as diagnostic biomarkers and therapeutic targets in BC was also discussed.
Keywords: Biomarkers; Breast cancer; Cell proliferation; Invasion; Long non-coding RNAs; Metastasis.
Copyright © 2021. Published by Elsevier Inc.
Similar articles
-
Emerging roles of long non-coding RNAs in breast cancer biology and management.Semin Cancer Biol. 2021 Jul;72:36-45. doi: 10.1016/j.semcancer.2020.06.019. Epub 2020 Jun 30. Semin Cancer Biol. 2021. PMID: 32619506 Review.
-
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2. J Transl Med. 2018. PMID: 30261893 Free PMC article.
-
Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review.Int J Biol Macromol. 2024 May;266(Pt 2):131075. doi: 10.1016/j.ijbiomac.2024.131075. Epub 2024 Mar 24. Int J Biol Macromol. 2024. PMID: 38531528 Review.
-
Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance.Oncogene. 2020 Jan;39(5):953-974. doi: 10.1038/s41388-019-1040-y. Epub 2019 Oct 10. Oncogene. 2020. PMID: 31601996 Review.
-
Long Non-Coding RNA and Breast Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819843889. doi: 10.1177/1533033819843889. Technol Cancer Res Treat. 2019. PMID: 30983509 Free PMC article. Review.
Cited by
-
Emerging Roles of Long Noncoding RNAs in Breast Cancer Epigenetics and Epitranscriptomics.Front Cell Dev Biol. 2022 Jul 5;10:922351. doi: 10.3389/fcell.2022.922351. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35865634 Free PMC article. Review.
-
Long noncoding RNA LINC02568 sequesters microRNA-874-3p to facilitate malignancy in breast cancer cells via cyclin E1 overexpression.Oncol Res. 2022 Aug 31;29(4):291-303. doi: 10.32604/or.2022.025172. eCollection 2021. Oncol Res. 2022. PMID: 37303942 Free PMC article.
-
A Fluorescent Reverse-Transcription Assay to Detect Chemical Adducts on RNA.Biochemistry. 2022 Aug 16;61(16):1665-1668. doi: 10.1021/acs.biochem.2c00270. Epub 2022 Jul 25. Biochemistry. 2022. PMID: 35876726 Free PMC article.
-
Long noncoding RNA PPP1R14B-AS1 imitates microRNA-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1.Oncol Res. 2022 Aug 31;29(4):251-262. doi: 10.32604/or.2022.03582. eCollection 2021. Oncol Res. 2022. PMID: 37303940 Free PMC article.
-
Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview.Cells. 2022 Apr 17;11(8):1367. doi: 10.3390/cells11081367. Cells. 2022. PMID: 35456047 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous